Clinical Trial Update: The Efficacy and Safety of a Compound Glutamine Capsule in the Primary Prevention of Chemotherapy-induced Mucositis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a glutamine capsule for primary prevention of chemotherapy-induced mucositis; efficacy and safety updates are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapeutic Toxicity
• Mucositis

Drugs mentioned

• Glutamine Capsule (compound glutamine) (glutamine)

Snippet

Sponsor: Meng Qiu | Conditions: Mucositis, Chemotherapeutic Toxicity | Phase 3 | Status: UNKNOWN